These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 18303288)

  • 21. Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography.
    Fayad LM; Holland GA; Bergin D; Iqbal N; Parker L; Curcillo PG; Kowalski TE; Park P; Intenzo C; Mitchell DG
    J Magn Reson Imaging; 2003 Oct; 18(4):449-60. PubMed ID: 14508782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right-lobe living related liver transplantation: evaluation of a comprehensive magnetic resonance imaging protocol for assessing potential donors.
    Goyen M; Barkhausen J; Debatin JF; Kühl H; Bosk S; Testa G; Malago M; Ruehm SG
    Liver Transpl; 2002 Mar; 8(3):241-50. PubMed ID: 11910569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries.
    Neira C; Anzidei M; Napoli A; Kirchin MA; Cavallo Marincola B; Zaccagna F; Catalano C; Passariello R; Tedoldi F
    Invest Radiol; 2011 Dec; 46(12):774-82. PubMed ID: 21730871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
    Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW
    Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
    Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
    J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): comparison of 3T vs. 1.5T.
    Arizono S; Isoda H; Maetani YS; Hirokawa Y; Shimada K; Nakamoto Y; Shibata T; Togashi K
    Eur J Radiol; 2010 Jan; 73(1):114-8. PubMed ID: 18834686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction.
    Lim JS; Kim MJ; Jung YY; Kim KW
    Korean J Radiol; 2005; 6(4):229-34. PubMed ID: 16374080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR cholangiopancreatography: comparison of 2D single-shot fast spin-echo and 3D fast spin-echo sequences.
    Cova M; Stacul F; Cester G; Ukmar M; Pozzi Mucelli R
    Radiol Med; 2003 Sep; 106(3):178-90. PubMed ID: 14612839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA for preoperative biliary mapping: correlation with intraoperative cholangiography.
    Lee Y; Kim SY; Kim KW; Lee SS; Park SH; Byun JH; Lee MG
    Acta Radiol; 2015 Jul; 56(7):773-81. PubMed ID: 25080516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-resolution magnetic resonance cholangiography (MRC) with adaptive averaging: diagnostic performance evaluation.
    Sala E; Graves MJ; Abubacker Z; Kershaw LE; Black RT; Skinner J; Beavon R; Lomas DJ
    Clin Radiol; 2006 Sep; 61(9):766-70. PubMed ID: 16905384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
    Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
    AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High spatial resolution navigated 3D T1-weighted hepatobiliary MR cholangiography using Gd-EOB-DTPA for evaluation of biliary anatomy in living liver donors.
    Lee JH; Kim B; Kim HJ; Kim BW; Wang HJ; Kim JK
    Abdom Radiol (NY); 2018 Jul; 43(7):1703-1712. PubMed ID: 29450611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
    Sheppard D; Allan L; Martin P; McLeay T; Milne W; Houston JG
    J Magn Reson Imaging; 2004 Aug; 20(2):256-63. PubMed ID: 15269951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficiency of Gd-EOB-DTPA-enhanced magnetic resonance cholangiography in living donor liver transplantation: a preliminary study.
    Ogul H; Kantarci M; Pirimoglu B; Karaca L; Aydinli B; Okur A; Ozturk G; Kizrak Y
    Clin Transplant; 2014 Mar; 28(3):354-60. PubMed ID: 24506817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemic-type biliary lesions in liver transplant recipients: evaluation with magnetic resonance cholangiography.
    Boraschi P; Donati F; Gigoni R; Urbani L; Femia M; Cossu MC; Filipponi F; Falaschi F
    Transplant Proc; 2004 Nov; 36(9):2744-7. PubMed ID: 15621138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.